Challenges and opportunities in using residual newborn screening samples for translational research: workshop summary

"Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth.

These specimens also represent a potentially invaluable resource for public health and biomedical research.

The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."